Skip to main content

Table 1 Demographics and clinicopathologic characteristics of patients with gastric cancer

From: Prognostic value of preoperative body mass index for diabetic patients with non-metastasis gastric cancer: a single center experience

 

BMI < 19 kg/m2 (n = 29)

BMI ≥ 19 kg/m2 (n = 273)

P-value

H. pylori infection

 Y

2

6.9%

17

7.2%

0.975

 N

27

93.1%

220

92.8%

 

Age

56.69 ± 13.1

57 (30–79)

58.81 ± 11.27

59 (23–82)

 

Sex

     

 M

16

55.2%

180

75.9%

0.016

 F

13

44.8%

57

24.1%

 

CEA level

14.32 ± 4.53

11.58 ± 3.38

0.004

T category

 1a

–

–

22

9.3%

0.003

 1b

–

–

22

9.3%

0.002#

 2

3

10.3%

34

14.3%

 

 3

3

10.3%

25

10.5%

 

 4a

18

62.1%

127

53.6%

 

 4b

5

17.2%

7

3%

 

N category

 0

4

13.8%

79

33.3%

0.301

 1

7

24.1%

41

17.3%

0.082$

 2

7

24.1%

41

17.3%

 

 3a

6

20.7%

45

19%

 

 3b

5

17.2%

31

13.1%

 

TNM category

 IA

0

 

34

14.3%

0.213

 IB

1

3.4%

23

9.7%

0.002&

 IIA

3

10.3%

20

8.4%

 

 IIB

2

6.9%

27

11.4%

 

 IIIA

6

20.7%

31

13.1%

 

 IIIB

6

20.7%

37

15.6%

 

 IIIC

11

37.9%

65

27.4%

 
  1. M: male, F: female #: T4 VS T1-3, $: N3 VS N0-2, &: stage III VS stage I-II